Watson will market generic morning after pill
Watson Pharmaceuticals Inc. said Friday that it is preparing to sell a generic version of the "morning after" pill.By: The Associated Press, Superior Telegram
PARSIPPANY, N.J. (AP) — Watson Pharmaceuticals Inc. said Friday that it is preparing to sell a generic version of the "morning after" pill.
Watson said the Food and Drug Administration approved its generic version of Plan B One-Step, an emergency contraceptive made by Teva Pharmaceutical Industries Ltd.
The company said it will start shipping its generic version immediately, and will market the drug under the name Next Choice One Dose.
The pill contains progestin, and it is an emergency contraceptive used to prevent pregnancy following intercourse. Watson said U.S. sales of Plan B One-Step totaled $88 million over the 12 months ended May 31.
Shares of Watson Pharmaceuticals rose 22 cents to $75.39 in morning trading Friday. Shares of Teva picked up 23 cents to $40.30.
More from around the web
RSS Feeds